At TCG Lifesciences (TCGLS), our Drug Metabolism and Pharmacokinetics (DMPK) division supports drug discovery and development by providing integrated ADME and pharmacokinetic evaluation to guide the progression of promising molecules. With nearly two decades of experience, our team combines scientific expertise, advanced analytical platforms, and rigorous data quality standards to generate reliable, decision-enabling insights across preclinical stages.
Comprehensive DMPK capabilities including ADME studies, pharmacokinetic profiling, metabolite identification, and bioanalytical support.
Expertise supporting early discovery screening, lead optimisation, and advanced preclinical development stages.
Generation of high-quality ADME and PK data to inform compound selection, optimisation, and development strategies.
Advanced analytical platforms and state-of-the-art instrumentation enabling precise, efficient data generation.
Our DMPK Service Portfolio
